BB Biotech’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $201M | Buy |
2,978,134
+100,000
| +3% | +$6.74M | 5.05% | 7 |
|
|
2018
Q4 | $133M | Buy |
2,878,134
+680,203
| +31% | +$31.4M | 4.25% | 7 |
|
|
2018
Q3 | $170M | Hold |
2,197,931
| – | – | 4.49% | 7 |
|
|
2018
Q2 | $185M | Sell |
2,197,931
-337,322
| -13% | -$28.4M | 5.35% | 6 |
|
|
2018
Q1 | $207M | Sell |
2,535,253
-184,745
| -7% | -$15.1M | 5.73% | 7 |
|
|
2017
Q4 | $156M | Sell |
2,719,998
-30,000
| -1% | -$1.72M | 4.38% | 12 |
|
|
2017
Q3 | $184M | Sell |
2,749,998
-119,530
| -4% | -$7.98M | 5.08% | 9 |
|
|
2017
Q2 | $148M | Buy |
2,869,528
+30,000
| +1% | +$1.54M | 4.51% | 9 |
|
|
2017
Q1 | $166M | Buy |
2,839,528
+30,000
| +1% | +$1.75M | 5.42% | 6 |
|
|
2016
Q4 | $117M | Buy |
2,809,528
+160,000
| +6% | +$6.68M | 4.34% | 9 |
|
|
2016
Q3 | $140M | Buy |
2,649,528
+286,207
| +12% | +$15.1M | 4.92% | 8 |
|
|
2016
Q2 | $99M | Buy |
2,363,321
+203,400
| +9% | +$8.52M | 3.91% | 10 |
|
|
2016
Q1 | $87.7M | Hold |
2,159,921
| – | – | 3.49% | 10 |
|
|
2015
Q4 | $140M | Buy |
2,159,921
+50,000
| +2% | +$3.25M | 3.95% | 9 |
|
|
2015
Q3 | $149M | Buy |
2,109,921
+120,000
| +6% | +$8.47M | 4.72% | 7 |
|
|
2015
Q2 | $221M | Buy |
1,989,921
+140,000
| +8% | +$15.6M | 6% | 6 |
|
|
2015
Q1 | $174M | Sell |
1,849,921
-15,000
| -0.8% | -$1.41M | 5.2% | 5 |
|
|
2014
Q4 | $209M | Sell |
1,864,921
-25,600
| -1% | -$2.87M | 6.77% | 5 |
|
|
2014
Q3 | $116M | Buy |
1,890,521
+1,384,521
| +274% | +$84.9M | 4.72% | 8 |
|
|
2014
Q2 | $23.2M | Buy |
+506,000
| New | +$23.2M | 1.1% | 18 |
|